Vycellix's universal cell platform (VY-UC) represents a breakthrough solution to overcoming the central barrier to donor derived-therapies, preventing the host immune system's rapid elimination of allogeneic cells. https://t.co/IYF5RqsN40
.@Phacilitate .@vycellix#AdvancedTherapies It’s been an amazing & productive week at Phacilitate Advanced Therapies Week on Miami Beach… the ideal intersection of business & friendship with colleagues & partners!
Vycellix CEO, Dr. Evren Alici, delivered multiple talks on the power & promise of therapeutic NK cells targeting cancer at Advanced Therapies Week, Miami. #AdvancedTherapies@Phacilitate
#NK2023 .@SNI_NKMeeting .@NextGenNK_CC Vycellix team so proud to be part of the cell therapy revolution at NK2023 with a focus on advancing next-generation off-the-shelf NK cell immunotherapies with multi-antigen engagement.
Vycellix Presents Proof-of-Concept Data for VY-UC Single-Step CD45-Engager Allogeneic Cell Therapy Platform at the International Society for Cell & Gene Therapy (ISCT) Annual Meeting, Paris | Business Wire https://t.co/EiVj1GpjRO
Vycellix Founding CEO, Dr Evren Alici, presenting today at the Allogeneic Cell Therapies Summit, Boston. “Moving the Needle on Graft Rejection with Novel Strategies for T Cell Manipulation”
#AACR2023 Vycellix Scientific Advisory Board Member, Dr Kalle Malmberg, Oslo University Hospital, delivers off-the-shelf NK cell symposium presentation at the American Association of Cancer Research Annual Meeting in Orlando.
.@NextGenNK_CC#InnateKillerSummit2023 Vycellix Founding CEO, Dr Evren Alici, presents alternative to engineer immune-privileged, “off-the-shelf”, universal cells by leveraging novel CD45 engager to completely abrogate cellular immune response & obviate need for lymphodepletion!
Dynamic Plenary Session at #InnateKillerSummit2023 San Diego: Vycellix collaborator, Dr Bjorn Önfelt (Karolinska Institutet) & Vycellix Scientific Advisory Board Member, Dr Jeff Miller (U. Of Minnesota) report on the breakthrough progress for Natural Killer Cell immunotherapies.
Registration is now open for #NK2023! Welcome to the north on September 26-29, we look forward to hosting you in Oslo, Norway and learn and discuss everything new about NK cells! https://t.co/jjGkTMGX3K
#ash22 Fantastic presentations from the visionaries advancing breakthrough natural killer cell therapeutics, including Vycellix Scientific Advisory Board member, Dr. Jeff Miller, Univ. Of Minnesota
@FloridaEDC @bioflorida Limitless: Cancer Immunotherapy - Vycellix highlighted as leading life science innovator in Tampa Bay https://t.co/GOUZhqeGyY
#BioFL2022 Day 3 kicks off with breakfast @ 7:45am followed by a #CEO panel featuring @vycellix's Douglas W. Calder, @ultragenyx's Eduardo Thompson, @Medtronic Latin America's Juan Toro, and more.
Today's full schedule: https://t.co/AlSyep9lZx
@maria_cimpean@BioFlorida@SNI_NKMeeting@karolinskainst 🎰🎰🎰 Congrats Maria! You are a winner! Well done! Please visit the Vycellix website and email Doug Calder your address, and we will send you a Vycellix Osprey backpack! Thanks for playing! And keep up your important work to progress NK cells as breakthrough cell therapy!
.@BioFlorida .@SNI_NKMeeting .@karolinskainst To celebrate 1st NextGenNK meeting at Karolinska, Vycellix is giving away an awesome custom Osprey backpack to the 1st person who can guess where this photo was taken! We’ll start giving hints if guesses are wildly off base!
@davidgeores@BioFlorida@SNI_NKMeeting@karolinskainst I’m sorry; while Big Thunder Mountain is the “wildest ride in the wilderness” at Disney’s Magic Kingdom, your guess is incorrect. This photo was not taken at any of Disney’s global theme parks, however, Disney does have a theme park on this continent.